Center-Authored Papers

Filters: Author is Ruan, Yuhua  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2014
Jackson BJ, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G et al..  2014.  Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand.. Hepatitis research and treatment. 2014:296958. Abstract
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J et al..  2014.  Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand.. Drug and alcohol dependence. Abstract
Adult
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Buprenorphine
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Center-Authored Paper
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J et al..  2014.  Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand.. Drug and alcohol dependence. Abstract
China
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Female
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
HIV Infections
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Humans
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Incidence
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
July 2014
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J et al..  2014.  Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand.. Drug and alcohol dependence. Abstract
June 2014
Jackson BJ, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G et al..  2014.  Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand.. Hepatitis research and treatment. 2014:296958. Abstract
Male
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Naloxone
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Opiate Substitution Treatment
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Public Health Sciences Division
Jackson BJ, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G et al..  2014.  Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand.. Hepatitis research and treatment. 2014:296958. Abstract
Substance Abuse, Intravenous
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Thailand
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Treatment Outcome
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Vaccine and Infectious Disease Division
Jackson BJ, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G et al..  2014.  Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand.. Hepatitis research and treatment. 2014:296958. Abstract
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J et al..  2014.  Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand.. Drug and alcohol dependence. Abstract